Combined Use Of Antiplatelet, Gastric Acid Medications Following Heart Attack Or Angina Associated With Increased Risk Of Death, Hospitalization
Medical News Today
4th March 2009

Following an acute coronary syndrome such as a heart attack or unstable angina, patients who receive a medication to reduce the risk of gastrointestinal bleeding that may be associated with the use of the antiplatelet drug clopidogrel and aspirin have an increased risk of subsequent hospitalization for acute coronary syndrome or death, according to a study in the March 4 issue of JAMA.
4th March 2009

Following an acute coronary syndrome such as a heart attack or unstable angina, patients who receive a medication to reduce the risk of gastrointestinal bleeding that may be associated with the use of the antiplatelet drug clopidogrel and aspirin have an increased risk of subsequent hospitalization for acute coronary syndrome or death, according to a study in the March 4 issue of JAMA.
Latest news:
3rd November 2009 -
Innovative Imaging System To Study Sudden Cardiac Arrest
3rd November 2009 -
Benefits Of Taking Part In Clinical Trials
30th October 2009 -
ESC Events In Asia Tackle Management Of Diabetes And Cardiovascular Disease
29th October 2009 -
Heart Patients Running The Red Light On Traffic Restrictions
29th October 2009 -
Onset Medical Performs First Human Use Of The SoloPathâ„¢ Endovascular Access Catheter To Deliver Percutaneous Aortic Heart Valve
29th October 2009 -
New CVD Guidelines And Position Papers
27th October 2009 -
Emory Program, Heart Attack, Myocardial Infarction, Cardiovascular Outcomes Research and Epidemiology
27th October 2009 -
Capsule Endoscopy Safe For Patients With Implantable Cardiac Devices






